Novel Compounds as SMARCA2 Inhibitors for Treating Non-small Cell Lung Cancer.
Ram W Sabnis
原始摘要（英文原文）· Original abstract
Provided herein are novel compounds as SMARCA2 inhibitors, pharmaceutical compositions, use of such compounds in treating non-small cell lung cancer (NSCLE), and processes for preparing such compounds.